Author
Antoine Bougoüin
Also Known As
A. Bougouin, A. Bougoüin, Antoine Bougouin, Antoine Bougouïn, Antoine Bougoüin
39
Publications
4K
Citations
14
H-Index
36
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 9 | 9 | 1.7K |
2 | Immunology | 7 | 7 | 1.5K |
3 | Cell Biology | 4 | 4 | 1.3K |
4 | Health Sciences | 1 | 1 | 15 |
5 | Cellular Physiology | 1 | 1 | 15 |
Antoine Bougoüin
×
15
Publications
4K
Citations
14
H-Index
| Year | Citations | |
|---|---|---|
2020 | 1.8K | |
2022 | 690 | |
2021 | 515 | |
2022 | 235 | |
Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial Yann Vano, Réza Elaidi, Mostefa Bennamoun, UrologyOncologyGenitourinary CancerMedicineImmune Checkpoint Inhibitor | 2022 | 128 |
2022 | 118 | |
2020 | 101 | |
2023 | 81 | |
2021 | 77 | |
2022 | 60 |
Page 1
Page 1